CABG versus PCI in high-risk coronary revascularisation patients shows mixed outcomes over 5 years
New Surgery Options For High-Risk Heart Patients
This observational study emulation of 103,670 people requiring multivessel revascularisation compared CABG and PCI. Over 5 years, CABG showe…
New data shows heart surgery and stents work differently for older patients with kidney disease or heart failure.
Transcatheter valve replacement improves outcomes in severe tricuspid regurgitation
New Valve Fix Cuts Hospital Stays for Severe Heart Leak Patients
A randomized trial shows EVOQUE TTVR plus medical therapy outperforms medical therapy alone for severe tricuspid regurgitation, improving va…
A new minimally invasive valve replacement slashes hospital stays for severe heart leak patients especially those with the worst cases new l…
Meta-analysis links TNF pathway proteins to ischemic stroke risk and recurrence
Higher TNF proteins linked to increased stroke risk in large study
This meta-analysis of observational cohorts synthesizes evidence that circulating TNF pathway proteins are associated with incident and recu…
People with more TNF proteins in their blood had a higher chance of having a stroke. This was seen in two large groups of adults.
FDA Approves Crestor (rosuvastatin) for Cardiovascular Risk Reduction in Adults
FDA approves Crestor to prevent heart attacks and strokes in certain adults.
FDA approved Crestor (rosuvastatin) to reduce risk of major adverse cardiovascular events in adults without established coronary heart disea…
The FDA approved Crestor (rosuvastatin) to reduce the risk of heart attack, stroke, and related events in adults without heart disease but w…
Systematic review finds CCTA underestimates SYNTAX scores versus invasive angiography in coronary artery disease
Heart Scans May Miss Key Details About Artery Blockages
This systematic review and meta-analysis evaluated coronary CT angiography (CCTA) against invasive coronary angiography (ICA) in adult popul…
A common non-invasive heart scan may underestimate how severe your artery blockages really are, which could change whether you need a stent …
Omecamtiv mecarbil shows trend toward reduced serious arrhythmia risk in HFrEF post hoc analysis
Heart Drug Shows Promise Against Deadly Heart Rhythms
This post hoc analysis of a randomized controlled trial evaluated omecamtiv mecarbil versus placebo in 8232 participants with symptomatic ch…
A heart failure medication already shown to improve pumping strength may also protect against sudden cardiac arrest, especially in patients …
Beta-blocker therapy in AMI patients with preserved ejection fraction shows comparable outcomes to non-use
New analysis shows beta-blockers do not lower heart attack risks for most patients with strong hearts
This meta-analysis of randomized controlled trials evaluated beta-blocker therapy in 19,826 patients with acute myocardial infarction and pr…
A large study of nearly twenty thousand patients found that taking beta-blockers after a heart attack did not reduce the risk of dying or ha…
Systematic review and meta-analysis of erythropoiesis-stimulating agents in chronic heart failure and anaemia
New drugs help heart failure patients stay out of the hospital
This systematic review and meta-analysis evaluated erythropoiesis-stimulating agents (ESAs) in adults with chronic heart failure and anaemia…
A new review shows specific drugs can keep heart failure patients out of the hospital while improving their daily energy and movement.
Qiliqiangxin reduces cardiovascular events in heart failure with reduced ejection fraction across LVEF subgroups
Lower heart function gets worse care but this drug helps everyone equally
This post hoc analysis of a Phase 3 RCT in 3110 patients with symptomatic HFrEF found that adding qiliqiangxin to guideline-directed therapy…
This heart drug works for patients with weak hearts just as well as it does for those with slightly stronger pumps
Cardiac rehabilitation reduces major adverse cardiac events and mortality in coronary artery disease patients after PCI
After a Heart Attack, This Simple Program Could Save Your Life
This meta-analysis evaluated cardiac rehabilitation versus control in patients with coronary artery disease following percutaneous coronary …
A structured exercise and education program after heart stent surgery slashes the risk of dying from heart disease by nearly a third, a majo…
Meta-analysis finds no mortality difference for PCI with surgical backup
Heart Procedure Safe Without Surgery Team On Site
A meta-analysis examined percutaneous coronary intervention outcomes with and without surgical on-site backup. It found no significant diffe…
Major heart procedures are just as safe in hospitals without on-site heart surgeons, a large new review finds.
MUSKARDIA shows protective trend in stable CAD with reduced eGFR
This Heart Pill from Traditional Medicine Shows Surprising Kidney Protection
A subgroup analysis of a phase IV trial found MUSKARDIA may protect against cardiovascular events in stable CAD patients with reduced kidney…
A traditional Chinese medicine pill already used for heart disease may also shield the kidneys, offering new hope for millions with both con…